Private sector R&D spending hit $673 billion in 2022—75% of America’s record $892 billion total—primarily driven by companies’ confidence that patents will protect their massive investments. Research and development activities are incentivized by strong patent protection, which encourages ongoing investment and innovation. Yet most business leaders fundamentally misunderstand how patent protection creates competitive advantage, drives revenue, and enables the entire modern innovation economy.
In cutting-edge fields like artificial intelligence, patent filings have surged nearly exponentially over the past two decades, underscoring how vital IP protection has become for emerging technologies. Patents play a crucial role in protecting and enabling new technology, ensuring that innovators can capitalize on their advancements. Even software startups and SaaS companies now rely heavily on patents to safeguard novel processes and cloud-based innovations, securing market share and attracting investors in fiercely competitive markets.
The patent system forms the backbone of modern innovation, providing inventors with exclusive rights to their creations while simultaneously advancing scientific knowledge through required disclosure. Patents foster innovation by incentivizing ongoing research, development, and industry breakthroughs. From pharmaceutical companies investing billions in new drug development to tech startups protecting breakthrough algorithms, patents matter in ways that extend far beyond basic legal protection.
This comprehensive analysis explores the multifaceted importance of patents in today’s economy, examining how they provide essential legal safeguards, drive innovation and economic growth, create significant business value, enable market competitiveness, facilitate technology transfer, support different industries uniquely, and address key challenges in modern innovation.
Patents Provide Essential Legal Protection for Inventors and Businesses
Patent enforcement requires vigilance from owners—patents don’t automatically enforce themselves. However, having patents dramatically improves leverage in negotiations and litigation, often leading to favorable settlements or licensing deals rather than costly court battles.
Importantly, patent holders retain ownership of their inventions even when licensing them to others. This allows patent owners to generate income through licensing while maintaining control over their intellectual property.
Why Patents Are Important To Investors – Innovation and Economic Growth
The patent system fundamentally incentivizes innovation by guaranteeing inventors temporary exclusivity in exchange for public disclosure. This incentive structure helps solve a classic market failure. As economist Kenneth Arrow observed in 1962, competitive markets tend to under-invest in R&D because knowledge can “be appropriated only to a limited extent” once revealed.
Empirical data strongly support the correlation between robust patent protection and high innovation rates.
U.S. R&D expenditures reached $892 billion in 2022, with an estimated increase to $940 billion in 2023. Notably, about 75% of U.S. R&D is funded by the private sector (roughly $673 billion of the 2022 total), indicating that businesses are the primary engine of innovation investment. This enormous private R&D spending is incentivized essentially by the patent system—companies know that successful innovations will enjoy patent protection for their competitive advantage.
High-risk, high-reward industries illustrate this dynamic clearly. Pharmaceutical innovation requires 10–15 years of research and clinical trials, costing anywhere from $1 billion to $2.3 billion per new drug. These enormous costs and lengthy timelines would be nearly impossible to justify if competitors could immediately copy successful drugs after approval.
Statistical studies show that patent filings and technological innovation rise together. Both the British Industrial Revolution and the American innovation boom of the late 19th century coincided with major expansions and reforms of patent law. When the U.S. reformed its patent system in the 1800s to make patents cheaper and easier to obtain, patenting activity exploded, and America overtook Britain in invention and industrial growth.
Today, we’re seeing a global surge in patenting during the “Fourth Industrial Revolution” of digital and AI technologies. The World Intellectual Property Organization reports that global patent applications reached a record high of over 3.5 million in 2023, marking the fourth consecutive year of growth in worldwide filings.
Patents encourage not only initial invention but also knowledge diffusion in the long run. Patent applications must publicly disclose how inventions work in sufficient detail for others skilled in the field to replicate them. This technical information is published (usually 18 months after filing) even while patents are pending.
As a result, patents turn private R&D into public knowledge, creating a cycle where inventors get temporary head starts to profit while society gains knowledge upfront and full access later. This process fosters cumulative innovation, as new technological developments often build on the disclosed inventions, driving further advancements across industries. Once patents expire, the inventions enter the public domain, making them freely available for anyone to use, adapt, or improve, which further accelerates innovation.
A striking example is the Bayh-Dole Act of 1980, which allowed universities and small businesses to retain patent rights to inventions developed from federally funded research. The result was a surge in technology transfer from academia to industry. Between 1996 and 2020, academic patenting and licensing under Bayh-Dole led to the formation of over 17,000 startup companies and the disclosure of more than 420,000 inventions. It’s estimated that university-led innovations during that period contributed up to $1.9 trillion to U.S. economic output and 6.5 million jobs.
In just 2023 alone, U.S. universities and research institutions filed over 25,000 new invention disclosures, received approximately 7,400 patents, executed 92,000 licensing deals or options, and launched 903 startups. These outcomes demonstrate how robust IP rights unlock the value of basic research, encouraging partnerships that turn lab results into real-world products and companies.
Patents Create Significant Business Value and Revenue Opportunities
Beyond motivating laboratory innovation, patents represent valuable intangible assets that can be leveraged for diverse business strategies and revenue models. A well-crafted patent portfolio opens multiple avenues for generating income, often far beyond the inventor’s own manufacturing or sales.
Patent licensing represents one of the most significant opportunities. IBM provides a compelling example: historically generating over $1 billion annually in patent licensing revenue at its peak, IBM still made about $397 million in 2022 purely from IP licensing (excluding product sales). These figures demonstrate how a strong patent portfolio can effectively become a revenue-generating business of its own, providing a steady stream of income through ongoing licensing agreements.
For SaaS companies and tech startups, this revenue potential becomes particularly relevant when considering software process patents and AI-driven innovations. Our SaaS Patent Guide 2.0 details specific strategies for identifying licensable software innovations that can generate ongoing royalty streams.
Patents serve as collateral for financing, with lenders and investors recognizing them as valuable assets that provide a competitive advantage. For startups, having granted patents or pending applications can significantly boost valuation and credibility. Patents also reassure potential investors by demonstrating innovation and technological strength, making them more likely to provide funding. Venture capitalists often view strong patent portfolios as signs of defensible technology and barriers to entry against competitors, a critical factor in funding decisions.
Patents yield value through strategic sales and acquisitions. Google’s $12.5 billion acquisition of Motorola Mobility in 2012 was driven mainly by Motorola’s portfolio of over 17,000 patents (plus thousands more pending). Google was engaged in intense patent litigation around its Android operating system, and by acquiring Motorola’s patents, Google obtained ammunition to defend against lawsuits and negotiate cross-licenses. Just weeks before Google’s move, a consortium including Apple and Microsoft had paid $4.5 billion to purchase Nortel Networks’ patent portfolio of about 6,000 patents.
Patent portfolios enhance companies’ negotiating power and market positioning. Companies with numerous patents in their fields can enter cross-licensing agreements with competitors to gain freedom to operate. They can also deter lawsuits—if companies both have large patent portfolios, they’re less likely to sue each other frivolously because each side has “IP ammunition” for a countersuit, leading instead to cross-licenses or settlements.
Studies show that in technology sectors, substantial portions of firms’ market capitalizations can be attributed to intangible assets like IP. When evaluating biotech companies, investors heavily weigh the strength and breadth of patent portfolios (which protect drug candidates) in determining company valuations.
Patents are much more than legal shields—they’re business assets and financial instruments that can generate revenue directly through licensing fees, provide bargaining chips in collaborations, attract investment by signaling innovation leadership, and be sold or leveraged to realize their value.
Patents Enable Market Competitiveness and Strategic Positioning
Exclusive patent rights allow companies to secure dominant positions in lucrative market segments and charge premium prices, at least until patent protection expires. A patent gives its owner a temporary monopoly on the patented innovation, often translating to significant competitive advantages that can determine success or failure in high-tech and high-investment industries.
Blockbuster pharmaceutical drugs dramatically illustrate the market power conferred by patents. When companies hold patents on breakthrough drugs, they typically enjoy years of market exclusivity during which they can set prices without competition from generics. The anti-inflammatory biologic drug Humira was protected by a web of patents that kept competitors at bay for about 15 years; in that time, Humira became the world’s top-selling drug with cumulative sales of around $200 billion before biosimilars finally emerged.
Patents are critical for maintaining a first-mover advantage. In fast-moving markets like consumer electronics or software, being first to introduce new features or technology can create leads. Still, without patents, those leads may be fleeting as rivals quickly copy innovations. With patent protection, however, innovators can lock in their first-mover gains for more extended periods, as competitors are legally barred from introducing copycat products until patents expire.
For AI and machine learning innovations, this first-mover advantage becomes particularly valuable. As detailed in our AI Patent Mastery resource, companies that strategically patent their AI algorithms and training methodologies can maintain competitive moats even as the underlying technology rapidly evolves.
Cross-licensing agreements represent another strategic use of patents. In industries where products incorporate many patented components (like smartphones, computers, or telecommunications), companies often hold patents that each other need. Rather than suing endlessly, they frequently reach cross-license deals: mutual permission to use each other’s patents. These agreements allow both parties to innovate freely while reinforcing their mutual dominance by raising barriers to entry for outsiders.
Patent portfolios also influence corporate negotiations and market structure. Companies with valuable patents might attract acquirers who want those IP assets, or conversely, having patent portfolios might dissuade hostile takeovers due to litigation risks. In licensing negotiations, sides with stronger patent positions often command higher royalties or better cross-license terms.
Patents can influence market structure and consumer choice by conferring exclusivity that leads to temporary monopolies or oligopolies in specific product categories. For consumers, this can mean higher prices in the short term (since competition is limited). Still, it also means access to innovative products that might not have existed without the incentive patents provided. After patents expire, competition usually increases and prices drop, as seen with generic drugs or off-patent technologies.
Patents Facilitate Technology Transfer and Commercialization
Patents play fundamental roles in bridging the gaps between invention and commercialization. Often, groundbreaking research originates in universities, government labs, or small inventor workshops that lack the capacity or resources to bring products to market at scale. Patents provide mechanisms to transfer these innovations to entities that can develop and distribute them by creating tradable assets.
Technology transfer commonly refers to processes by which discoveries made in research institutions are turned into commercial products by industry. Universities typically have technology transfer offices (TTOs) that evaluate inventions arising from academic research. If inventions have commercial promise, universities file patent applications. With patents in hand, TTOs can license technology to companies that have the means to develop it. Patents are essential for product inventions, as they enable the commercialization of new products and facilitate their transfer from research institutions to industry. From 1996 to 2023, the Bayh-Dole framework led to over 18,000 startups formed from university inventions and more than 554,000 inventions disclosed at academic institutions.
Universities executed nearly 9,300 licenses in 2023 alone, each representing technology being handed off to companies for market development, underpinned by patents or pending patents.
One prominent example involves CRISPR gene-editing technology, which originated from basic research in academic labs at UC Berkeley and the Broad Institute. Both institutions obtained patents on different aspects of CRISPR gene-editing, which have since been licensed to multiple biotechnology companies and startups focusing on therapeutic applications and agricultural biotech.
Patents empower independent inventors and small businesses to participate in commercialization. Individual inventors who develop novel technologies might lack manufacturing bases or capital to commercialize widely, but with secured patents, they can license inventions to larger companies or sell patents outright. This creates markets for ideas, enabling inventors to specialize in inventing while businesses that excel at scaling products acquire rights to do so. Patents can protect not only processes but also articles of manufacture, ensuring that a wide range of innovations—including tangible products—are eligible for legal protection and subsequent commercialization.
The patent system encourages openness and collaboration rather than secrecy. In the absence of patents, inventors might keep processes or formulas as trade secrets to prevent copying. But trade secrets can be limiting—once someone else independently discovers the same idea, or if secrets leak, the original inventors have no recourse. Patents solve this by trading secrecy for protection: disclose innovations publicly in patents, and in return get temporary monopolies.
Mechanisms like the Patent Cooperation Treaty (PCT) facilitate technology transfer by simplifying the processes of seeking patent protection in multiple countries. Under the PCT, inventors can file one international application that can later be nationalized in over 150 member countries, preserving priority dates. This is crucial because modern industries are global—innovators need to protect their IP in all significant markets.
The Bayh-Dole Act demonstrates how government policy can amplify technology transfer. From 1991 to 2018, annual U.S. university patent grants grew from under 1,000 to about 7,700, and by 2018, university licensing income exceeded $2.9 billion. Hundreds of new products (including drugs and vaccines) reached the public as direct consequences of these partnerships. Additionally, over 200 new drugs and vaccines were developed through public-private collaborations enabled by Bayh-Dole as of 2020.
Patents Support Different Industries in Unique Ways
While patent importance is broad-based, the roles they play vary significantly across different industries. The Patent Act serves as the legal foundation that governs patent rights and their application across all sectors, ensuring a consistent framework for what qualifies as patentable subject matter and how disputes are resolved. Each industry has its own innovation dynamics, R&D costs, and competitive challenges, leading to unique patterns in how patents protect and propel progress.
Pharmaceutical Industry
Nowhere are patents more critical than in pharmaceuticals. Developing new drugs is extremely costly and lengthy, often requiring decades of research, clinical trials, and regulatory review, with average costs frequently cited in the $1–2.8 billion range per successful drug. Patents are absolutely vital for recouping these massive investments. The creation of new pharmaceuticals is highly dependent on patent-driven incentives, as patents play a crucial role in encouraging companies to undertake the high costs and risks associated with developing innovative medicines.
Without 20-year patent terms (of which effective market exclusivity might be ~10-14 years post-approval), generic manufacturers could copy drugs’ active ingredients as soon as they’re approved, making it virtually impossible for innovator companies to recover R&D costs. Thus, pharma companies structure entire business models around patent-protected medicines.
They often file multiple patents per drug (covering compounds, formulations, manufacturing processes, specific medical uses, etc.) to build protective moats. During patent periods, companies have monopolies on sales, allowing them to set higher prices that fund not only production and distribution but also research on other new drugs (including many that fail in trials).
Software and Technology Companies
In the software and broader tech industry, patents are both tools of innovation protection and pieces in high-stakes strategic games. Tech companies like IBM, Microsoft, Google, Apple, and Samsung obtain thousands of patents annually, covering algorithms, user interface designs, hardware architectures, networking protocols, and more.
These patents serve multiple purposes: offensively, they let companies stop competitors from using certain features or methods; defensively, they act as deterrents since competitors are less likely to sue for patent infringement if you have stockpiles of patents for counter-suits.
However, software patents have been controversial. The Alice Corp. v. CLS Bank (2014) Supreme Court decision imposed stricter limits on abstract software patents, which helped refocus software patenting on more concrete technical innovations. The United States Patent and Trademark Office (USPTO), as the federal agency responsible for examining and granting United States patents, plays a central role in determining which software-related inventions meet the legal standards for patentability.
Still, tech companies vigorously patent genuine innovations in AI, cloud computing, cybersecurity, etc. According to USPTO data, AI-related patent applications in the U.S. have increased by about 33% since 2018. Moreover, filings for generative AI patents surged over 50% in the past year, surpassing 51,400 filings, reflecting intense competition in that arena.
For SaaS companies, the key is identifying patentable technical improvements in software architecture, data processing methods, and user interface innovations that go beyond abstract business methods. Our experience shows that SaaS platforms with strong patent portfolios consistently command higher valuations during funding rounds and acquisition discussions.
Manufacturing and Engineering Industries
Traditional manufacturing industries, from automotive to electronics to industrial machinery, rely on patents to protect both product innovations and process innovations. An automaker might patent new types of fuel injection systems or battery technology (product innovation), as well as new assembly line techniques or robotic tools for manufacturing (process innovation).
Patents on processes are particularly important in manufacturing because clever production methods can significantly lower costs or improve quality, advantages that companies want to keep to themselves. Manufacturing firms often use combinations of patents and trade secrets, patenting specific inventions while keeping broader know-how secret.
Biotechnology Sector
Biotechnology lies at the intersection of science and industry, where patents are the lifeblood. Biotech startups are often founded around single core inventions—methods to edit genes (like CRISPR), novel antibody therapies, new diagnostic tests, or bioengineered materials.
These companies usually operate for years on R&D funding (often venture capital or grants) without product revenue, hoping to develop successful drugs or technologies. Their patents are frequently their most valuable assets during development phases. Strong patent portfolios enable startups to raise capital—investors see that if science works, companies will have exclusive rights to it, potentially leading to huge payoffs.
Medical Device Industry
The medical device industry, including everything from surgical instruments and implants to imaging machines and digital health tools, depends on patents to protect engineering innovations that improve patient care. Medical devices often face relatively shorter development cycles and slightly lower regulatory hurdles than drugs (though still significant), so competition can be intense.
Patents on novel devices (e.g., stents with new designs, pacemakers with improved software, minimally invasive surgical tools) give inventor companies periods to establish themselves in hospitals and clinics before competitors can enter the market.
Patents Address Key Challenges in Modern Innovation
The patent system exists to address fundamental challenges at the heart of innovation-driven economies. By design, it tries to balance competing interests: the need to reward inventors and encourage investment versus the need to disseminate knowledge and allow competition eventually. The classic market failure in innovation is that, without patents, inventors wouldn’t have sufficient incentive to innovate because they couldn’t stop imitators from free-riding on their ideas.
However, patents also introduce issues that must be managed. One is that while they restrict competition, they shouldn’t do so excessively or indefinitely. The temporary nature of patents (20-year terms for utility patents in most countries) is one safeguard. Another issue is patent quality: if patents are granted too broadly or for trivial inventions, they can stifle innovation rather than promote it. Modern patent offices face challenges of examining ever-growing numbers of applications (the USPTO receives hundreds of thousands per year) while ensuring only truly novel, non-obvious, and useful inventions get through.
A contemporary challenge is patent litigation and the rise of patent assertion entities (PAEs), often called patent trolls. These are companies that primarily exist to enforce patent rights rather than produce products. Data indicates that roughly 60% of U.S. patent lawsuits in 2022 were filed by non-practicing entities. This has led to debates on legal reforms, such as changing venue rules and fee-shifting to deter frivolous cases.
Globalization has added complexity as innovation becomes international while patent rights remain territorial. Countries have forged international agreements to harmonize and cooperate on IP. The Patent Cooperation Treaty (PCT) of 1970 significantly streamlined processes for inventors seeking multi-country protection—it has over 150 contracting states. Under the PCT, one can file an “international” application, which eventually branches into national applications. It is increasingly vital for inventors to seek patent protection in other countries, not just the U.S., to ensure their innovations are safeguarded in key global markets.
Despite harmonization efforts, differences remain in patent laws across countries. For example, what’s considered patentable subject matter can vary—software or methods of medical treatment are treated differently in some jurisdictions. This means companies must tailor their IP strategies by region.
Modern challenges include keeping patent systems agile enough for new technologies. Artificial intelligence raises questions: Can inventions created by AI be patented? How should AI-related inventions be examined for obviousness when AI can churn out many potential solutions? The USPTO has been grappling with AI-guidance, issuing guidance on AI patent subject matter eligibility in 2024 to help examiners consistently handle AI innovations.
Patent races in emerging industries also create challenges. The global race for leadership in 5G technology saw companies like Qualcomm, Huawei, Nokia, and Ericsson amassing thousands of patents each. China continues to lead globally in patent filings.
According to the World Intellectual Property Indicators 2024, individuals and entities in China filed approximately 1.64 million patent applications in 2023, significantly higher than any other country, with the U.S. coming in second at about 518,000 filings. This figure reinforces China’s dominant lead in global patent activity..
Modern innovation increasingly involves open source and open science movements, which at first glance seem at odds with patents. The patent system can accommodate this—inventors are never forced to patent; it’s opt-in. Some companies use mixed approaches: patent core tech but open-source other parts to build community adoption.
Looking ahead, the patent system must continue evolving. Issues like patenting algorithms, data, and AI-generated inventions, patents in space or on new materials, ensuring patent accessibility for small inventors—these are all on the horizon. The core principle remains: encourage innovation while eventually spreading its benefits.
Your Next Steps to Patent Protection Success
Understanding why patents are essential is just the beginning—the real value comes from developing and executing a strategic IP protection plan tailored to your specific innovations and business goals. Whether you’re a SaaS founder protecting breakthrough algorithms, a biotech startup securing gene therapy innovations, or a manufacturing company safeguarding process improvements, the right patent strategy can transform your competitive position.
The bottom line: weak patents help your competitors more than they help you, while strong patents create genuine barriers to entry and revenue opportunities that compound over time. The difference between a defensive patent portfolio and a truly strategic one often determines which companies capture market leadership and which ones struggle to maintain relevance.
Time is your enemy in patent protection. Every day you delay filing gives competitors opportunities to develop similar solutions, and our first-to-file system means that being second to the USPTO is the same as being last to market. Meanwhile, inadequate patent applications can actually harm your position by creating prior art that prevents stronger future filings while providing no real protection.
Here’s your immediate action plan:
- Schedule a free IP strategy call to evaluate your innovations’ patentability and develop a comprehensive protection strategy that aligns with your business goals and funding timeline.
- Conduct a thorough IP audit of your current innovations, including software processes, hardware designs, manufacturing methods, and business systems that could qualify for patent protection.
- Analyze your competitive landscape to identify white space opportunities and ensure your innovations don’t infringe existing patents while positioning your applications for maximum strategic value.
- Develop your international filing strategy using PCT applications to secure global priority dates while managing costs through strategic national phase entries in key markets.
- Create your patent portfolio roadmap that balances immediate protection needs with long-term licensing opportunities and potential exit strategies.
Strong patent protection isn’t just legal insurance—it’s a fundamental business asset that creates licensing revenue, attracts investors, deters competitors, and enables strategic partnerships that drive growth. Companies with robust IP portfolios consistently achieve higher valuations, better financing terms, and more favorable acquisition multiples than those that treat patents as afterthoughts.
The RLG Guarantee for Patent Applications:
- FREE strategy call with RLG’s experienced patent team
- Experienced US patent attorneys lead your application from start to finish
- One transparent flat fee covering your entire patent application process
- Full refund if USPTO denies your patent application*
- Complete refund or additional searches if your invention has patentability issues (your choice)*
Don’t let uncertainty about costs or outcomes delay your IP protection strategy. Our fixed-fee model eliminates the unpredictability of hourly billing while our guarantee ensures you only pay for results.
Connect with us on social:
- Twitter/X: @rapackelaw
- Instagram: @rapackelaw
To Your Success,
Andrew Rapacke, Managing Partner
Registered Patent Attorney
Rapacke Law Group
